MENU
ARTV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Artiva Biotherapeutics (ARTV) Ownership - Who owns Artiva Biotherapeutics?
Artiva Biotherapeutics Inc is a biopharmaceutical company... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
48.24M
P/E Ratio
N/A
Total Cash
165.96M
Projected Growth
N/A
Total Debt
14M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ARTV
Capitalization
48.2M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
166M
Total Cash/Share
6.81
Total Debt
14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
169M
P/B Ratio
0.29
Cash Flow
N/A
Earnings
-6.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
13.93
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-72.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.08
Shares Held By Institutions
79.9M
Shares Outstanding - Current
24.4M
Total Liabilities
22.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-80.357
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information